Alebund Pharmaceuticals
About:
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.
Website: http://www.alebund.com
Top Investors: Lilly Asia Ventures, BioVenture, Octagon Capital Advisors, Verition Fund Management, 3E Bioventures
Description:
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions.
Total Funding Amount:
$260M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2018-01-01
Contact Email:
communication(AT)alebund.com
Founders:
Gavin Xia, Jin Tian
Number of Employees:
101-250
Last Funding Date:
2023-04-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai